Riskpilot← Back to searchSign inGet full accessScandinavian Biolabs ApS
APSActiveCVR 41170514Kronprinsessegade 54, 4. tvWholesale of perfume and cosmetics · NACE 4645Est. 202020 employeeswww.scandinavianbiolabs.com
Revenue 2024
DKK -519K
-110% vs 2023
EBITDA margin
1480.9%
-822% vs 2023
Equity ratio
51.2%
Financial strength
Net profit 2024
DKK -8,8M
-548% vs 2023
| Revenue | DKK -519K | -110% |
| EBITDA | DKK -7,7M | -822% |
| Net profit | DKK -8,8M | -548% |
| Total assets | DKK 34,3M | +202% |
| Equity | DKK 17,6M | +1469% |
| Employees | 20 | — |
Legal name
Scandinavian Biolabs ApS
CVR number
41170514
Legal form
Anpartsselskab
NACE code
4645 · Wholesale of perfume and cosmetics
Founded
5. februar 2020
Share capital
DKK 5.478.985
Employees
20 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsesformanden og én direktør i fællesskab eller af samtlige bestyrelsesmedlemmer.
Company purpose
Selskabets formål er at drive virksomhed med salg af varer online og i fysiske butikker samt andre relevante aktiviteter efter ledelsens vurdering.
Address
Kronprinsessegade 54, 4. tv
Phone
+4570605708
Email
nk@scandinavianbiolabs.com
Website
www.scandinavianbiolabs.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | -1.145 | -1.883 | 1.591 | 5.145 | -519 |
| Staff expenses | -620 | -2.692 | -4.006 | -5.979 | -7.166 |
| EBITDA | -1.775 | -4.575 | -2.415 | -834 | -7.685 |
| Depreciation & amort. | -5 | -14 | -0 | -0 | -0 |
| EBIT | -1.780 | -4.589 | -2.415 | -834 | -7.685 |
| Net financials | -1 | -23 | -101 | -520 | -1.088 |
| Profit before tax | -1.781 | -4.612 | -2.516 | -1.354 | -8.773 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | -1.781 | -4.612 | -2.516 | -1.354 | -8.773 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 479 | 2.545 | 3.692 | 11.348 | 34.295 |
| Equity | -1.741 | -3.415 | -5.930 | -1.284 | 17.571 |
| Long-term debt | 1.500 | 0 | 0 | 0 | 0 |
| Short-term debt | 720 | 5.959 | 9.622 | 12.632 | 16.724 |
| Total debt | 2.220 | 5.959 | 9.622 | 12.632 | 16.724 |
EBITDA margin
-768504600.0%
This company
15.8%
Market median
-4863953265% vs market
20202024
Equity ratio
51.2%
This company
38.2%
Market median
+34% vs market
20202024
Return on equity
-49.9%
This company
18.4%
Market median
-371% vs market
20202024
Net profit margin
-877334200.0%
This company
8.1%
Market median
-10831286520% vs market
20202024
Asset turnover
-0.02×
This company
1.12×
Market median
-102% vs market
20202024
Debt / equity
0.95×
This company
0.62×
Market median
+53% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-02-05 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CF Management | Management | 2020 | — | — |
CN Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
BLAZAR ApS | Company | 33.3% | 33.3% | 2020 |
| Individual | 25.0% | 25.0% | 2025 | |
| Individual | 10.0% | 10.0% | 2025 | |
Reckendorff Holding ApS | Company | 5.0% | 5.0% | 2021 |
| Individual | 0.0% | 5.0% | 2025 | |
| Individual | 0.0% | 5.0% | 2024 | |
NieKon ApS | Company | 5.0% | 5.0% | 2021 |
C. Haslund Holding ApS | Company | 5.0% | 5.0% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ARNSTEDT HOLDING ApS
Scandinavian Biolabs ApS Board members of Scandinavian Biolabs ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christian Fogh Harboe | Management | 0 companies |
| Christopher Nørgaard Haslund | Chief Executive Officer | 0 companies |
| Samuel Meeker Kaplan | Board of Directors | 0 companies |
| Pascar Paw Paramasivam | Board of Directors | 0 companies |
| Mitesh Jatania | Chairman | 0 companies |